Cordyceps militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-κB Redox Signaling Pathway. (31st March 2019)
- Record Type:
- Journal Article
- Title:
- Cordyceps militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-κB Redox Signaling Pathway. (31st March 2019)
- Main Title:
- Cordyceps militaris Improves Chronic Kidney Disease by Affecting TLR4/NF-κB Redox Signaling Pathway
- Authors:
- Sun, Tingli
Dong, Wenpeng
Jiang, Guohong
Yang, Jingbo
Liu, Jizhang
Zhao, Lijie
Ma, Peilong - Other Names:
- Khan Abdul H. Guest Editor.
- Abstract:
- Abstract : Cordyceps militaris may show good promise in protecting against chronic kidney disease (CKD) but the molecular mechanism remains unclear. CKD risk is associated with the Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF- κ B) signaling pathway. Cordycepin is the main component of Cordyceps militaris and may affect the TLR4/NF- κ B pathway. Cordycepin was prepared by preparative HPLC. CKD patients were assigned into Cordyceps militaris (COG, 100 mg daily) and placebo (CG) groups. Cordycepin activity was measured using human embryo kidney cells (HEK293T). Biochemical indices, the levels of TLR4, NF- κ B, cyclooxygenase-2 (COX2), tumor necrosis factor-alpha (TNF- α ), and interleukin-1 beta (IL-1 β ), were measured by real-time qRT-PCR, or ELISA kits and or Western blot. After 3-month treatment, cordycepin reduced the levels of urinal protein, blood urea nitrogen (BUN), and creatinine by36.7 % ± 8.6 %, 12.5 % ± 3.2 %, and18.3 % ± 6.6 %, respectively (P < 0.05 ). Cordyceps militaris improved lipid profile and redox capacity of CKD patients by reducing the serum levels of TG, TC, and LDL-C by12.8 % ± 3.6 %, 15.7 % ± 4.1 %, and16.5 % ± 4.4 % and increasing the HDL-C level by10.1 % ± 1.4 % in the COG group when compared with the CG group, respectively (P < 0.05 ). The serum levels of cystatin-C (Cys-C), myeloperoxidase (MPO), and malondialdehyde (MDA) were reduced by14.0 % ± 3.8 %, 26.9 % ± 12.3 %, and19.7 % ± 7.9 % while nitric oxide (NO) and superoxide dismutaseAbstract : Cordyceps militaris may show good promise in protecting against chronic kidney disease (CKD) but the molecular mechanism remains unclear. CKD risk is associated with the Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF- κ B) signaling pathway. Cordycepin is the main component of Cordyceps militaris and may affect the TLR4/NF- κ B pathway. Cordycepin was prepared by preparative HPLC. CKD patients were assigned into Cordyceps militaris (COG, 100 mg daily) and placebo (CG) groups. Cordycepin activity was measured using human embryo kidney cells (HEK293T). Biochemical indices, the levels of TLR4, NF- κ B, cyclooxygenase-2 (COX2), tumor necrosis factor-alpha (TNF- α ), and interleukin-1 beta (IL-1 β ), were measured by real-time qRT-PCR, or ELISA kits and or Western blot. After 3-month treatment, cordycepin reduced the levels of urinal protein, blood urea nitrogen (BUN), and creatinine by36.7 % ± 8.6 %, 12.5 % ± 3.2 %, and18.3 % ± 6.6 %, respectively (P < 0.05 ). Cordyceps militaris improved lipid profile and redox capacity of CKD patients by reducing the serum levels of TG, TC, and LDL-C by12.8 % ± 3.6 %, 15.7 % ± 4.1 %, and16.5 % ± 4.4 % and increasing the HDL-C level by10.1 % ± 1.4 % in the COG group when compared with the CG group, respectively (P < 0.05 ). The serum levels of cystatin-C (Cys-C), myeloperoxidase (MPO), and malondialdehyde (MDA) were reduced by14.0 % ± 3.8 %, 26.9 % ± 12.3 %, and19.7 % ± 7.9 % while nitric oxide (NO) and superoxide dismutase (SOD) were increased by12.5 % ± 2.9 % and25.3 % ± 13.4 % in the COG group when compared with the CG group, respectively (P < 0.05 ). Cordycepin reduced the levels of TLR4, NF- κ B, COX2, TNF- α, and IL-1 β in HEK293T cells too (P < 0.05 ). However, cordycepin could not affect the levels anymore if TLR4 was silenced. Cordyceps militaris protected against CKD progression by affecting the TLR4/NF- κ B lipid and redox signaling pathway via cordycepin. … (more)
- Is Part Of:
- Oxidative medicine and cellular longevity. Volume 2019(2019)
- Journal:
- Oxidative medicine and cellular longevity
- Issue:
- Volume 2019(2019)
- Issue Display:
- Volume 2019, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 2019
- Issue:
- 2019
- Issue Sort Value:
- 2019-2019-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-03-31
- Subjects:
- Oxidative stress -- Periodicals
Cells -- Aging -- Periodicals
Cells -- Aging
Oxidative stress
Oxidative Stress -- Periodicals
Cell Aging -- Periodicals
Periodicals
611.0181 - Journal URLs:
- https://www.hindawi.com/journals/omcl/ ↗
- DOI:
- 10.1155/2019/7850863 ↗
- Languages:
- English
- ISSNs:
- 1942-0900
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10442.xml